These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

551 related articles for article (PubMed ID: 9361056)

  • 21. Prognostic factors for deep situated malignant gliomas treated with linac radiosurgery.
    Wang YY; Yang GK; Li SY; Baol XF; Wu CY
    Chin Med Sci J; 2004 Jun; 19(2):105-10. PubMed ID: 15250245
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term seizure outcomes in adult patients undergoing primary resection of malignant brain astrocytomas. Clinical article.
    Chaichana KL; Parker SL; Olivi A; Quiñones-Hinojosa A
    J Neurosurg; 2009 Aug; 111(2):282-92. PubMed ID: 19344222
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Volumetric extent of resection and residual contrast enhancement on initial surgery as predictors of outcome in adult patients with hemispheric anaplastic astrocytoma.
    Keles GE; Chang EF; Lamborn KR; Tihan T; Chang CJ; Chang SM; Berger MS
    J Neurosurg; 2006 Jul; 105(1):34-40. PubMed ID: 16871879
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of extent of resection for recurrent glioblastoma on overall survival: clinical article.
    Bloch O; Han SJ; Cha S; Sun MZ; Aghi MK; McDermott MW; Berger MS; Parsa AT
    J Neurosurg; 2012 Dec; 117(6):1032-8. PubMed ID: 23039151
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term outcome of patients with WHO Grade III and IV gliomas treated by fractionated intracavitary radioimmunotherapy.
    Reulen HJ; Poepperl G; Goetz C; Gildehaus FJ; Schmidt M; Tatsch K; Pietsch T; Kraus T; Rachinger W
    J Neurosurg; 2015 Sep; 123(3):760-70. PubMed ID: 26140493
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selection of eligible patients with supratentorial glioblastoma multiforme for gross total resection.
    Shinoda J; Sakai N; Murase S; Yano H; Matsuhisa T; Funakoshi T
    J Neurooncol; 2001 Apr; 52(2):161-71. PubMed ID: 11508816
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Malign transformation in the low grade astrocytomas and related factors.
    Kamasak K; Ekici MA; Gocmez C; Tucer B; Basarslan SK; Kurtsoy A
    Turk Neurosurg; 2012; 22(5):566-75. PubMed ID: 23015332
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Positive influence of partial resection on overall survival of patients with overlapping glioblastomas.
    Quick-Weller J; Tritt S; Baumgarten P; Konczalla J; Kashefiolasl S; Noack A; Tichy J; Seifert V; Marquardt G
    Clin Neurol Neurosurg; 2017 Oct; 161():22-28. PubMed ID: 28837843
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival.
    Lacroix M; Abi-Said D; Fourney DR; Gokaslan ZL; Shi W; DeMonte F; Lang FF; McCutcheon IE; Hassenbusch SJ; Holland E; Hess K; Michael C; Miller D; Sawaya R
    J Neurosurg; 2001 Aug; 95(2):190-8. PubMed ID: 11780887
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhancing tumor apparent diffusion coefficient histogram skewness stratifies the postoperative survival in recurrent glioblastoma multiforme patients undergoing salvage surgery.
    Zolal A; Juratli TA; Linn J; Podlesek D; Sitoci Ficici KH; Kitzler HH; Schackert G; Sobottka SB; Rieger B; Krex D
    J Neurooncol; 2016 May; 127(3):551-7. PubMed ID: 26830088
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of the mortality probability of preoperative MRI features in malignant astrocytomas.
    Ekici MA; Bulut T; Tucer B; Kurtsoy A
    Turk Neurosurg; 2011; 21(3):271-9. PubMed ID: 21845561
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multimodality management of recurrent adult malignant gliomas: results of a phase II multiagent chemotherapy study and analysis of cytoreductive surgery.
    Rostomily RC; Spence AM; Duong D; McCormick K; Bland M; Berger MS
    Neurosurgery; 1994 Sep; 35(3):378-88; discussion 388. PubMed ID: 7800129
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Extent of surgical resection of malignant astrocytomas of the spinal cord: outcome analysis of 35 patients.
    McGirt MJ; Goldstein IM; Chaichana KL; Tobias ME; Kothbauer KF; Jallo GI
    Neurosurgery; 2008 Jul; 63(1):55-60; discussion 60-1. PubMed ID: 18728568
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inability of computed tomography appearance of recurrent malignant astrocytoma to predict survival following reoperation.
    Wallner KE; Galicich JH; Malkin MG; Arbit E; Krol G; Rosenblum MK
    J Clin Oncol; 1989 Oct; 7(10):1492-6. PubMed ID: 2550591
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multi-center study finds postoperative residual non-enhancing component of glioblastoma as a new determinant of patient outcome.
    Kotrotsou A; Elakkad A; Sun J; Thomas GA; Yang D; Abrol S; Wei W; Weinberg JS; Bakhtiari AS; Kircher MF; Luedi MM; de Groot JF; Sawaya R; Kumar AJ; Zinn PO; Colen RR
    J Neurooncol; 2018 Aug; 139(1):125-133. PubMed ID: 29619649
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic sub-types of human malignant astrocytoma correlate with survival.
    Leenstra S; Oskam NT; Bijleveld EH; Bosch DA; Troost D; Hulsebos TJ
    Int J Cancer; 1998 Apr; 79(2):159-65. PubMed ID: 9583731
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of neuronavigation and image-guided extensive resection for adult patients with supratentorial malignant astrocytomas: a single-institution retrospective study.
    Kurimoto M; Hayashi N; Kamiyama H; Nagai S; Shibata T; Asahi T; Matsumura N; Hirashima Y; Endo S
    Minim Invasive Neurosurg; 2004 Oct; 47(5):278-83. PubMed ID: 15578340
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Infarct volume after glioblastoma surgery as an independent prognostic factor.
    Bette S; Wiestler B; Kaesmacher J; Huber T; Gerhardt J; Barz M; Delbridge C; Ryang YM; Ringel F; Zimmer C; Meyer B; Boeckh-Behrens T; Kirschke JS; Gempt J
    Oncotarget; 2016 Sep; 7(38):61945-61954. PubMed ID: 27566556
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of bromodeoxyuridine radiosensitization on malignant glioma patient survival: a retrospective comparison of survival data from the Northern California Oncology Group (NCOG) and Radiation Therapy Oncology Group trials (RTOG) for glioblastoma multiforme and anaplastic astrocytoma.
    Prados MD; Scott CB; Rotman M; Rubin P; Murray K; Sause W; Asbell S; Comis R; Curran W; Nelson J; Davis RL; Levin VA; Lamborn K; Phillips TL
    Int J Radiat Oncol Biol Phys; 1998 Feb; 40(3):653-9. PubMed ID: 9486616
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of Resection on Survival of Isocitrate Dehydrogenase 1-Mutated World Health Organization Grade II Astrocytoma After Malignant Progression.
    Grau SJ; Hampl JA; Kohl AC; Timmer M; Duval IV; Blau T; Ruge MI; Goldbrunner RH
    World Neurosurg; 2017 Jul; 103():180-185. PubMed ID: 28377251
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.